Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
前收盘价
US$91.93
+US$3.45 · +3.90%
盘前
US$92.61
+US$0.68 · +0.74%
10月13日 7:50 ET
盘中时间采用ET。市场数据可能有所延迟。
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
日内区间
当前US$91.93
52周区间
当前US$91.93
盘中时间采用ET。市场数据可能有所延迟。
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
日内区间
当前US$91.93
52周区间
当前US$91.93
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 363.64亿 USD | 335.37亿 USD | 323.64亿 USD | 312.27亿 USD | 316.86亿 USD |
| 销货成本 | 127.21亿 USD | 116.32亿 USD | 112.16亿 USD | 107.19亿 USD | 101.45亿 USD |
| 毛利 | 236.43亿 USD | 219.05亿 USD | 211.48亿 USD | 205.08亿 USD | 215.41亿 USD |
| 研究与开发 | 28.73亿 USD | 27.32亿 USD | 27.35亿 USD | 26.96亿 USD | 27.46亿 USD |
| 销售、一般及管理费用 | 117.84亿 USD | 108.49亿 USD | 107.36亿 USD | 104.15亿 USD | 102.92亿 USD |
| 营业费用 | 171.79亿 USD | 159.5亿 USD | 160.04亿 USD | 150.23亿 USD | 157.89亿 USD |
| 利息支出 | 7.15亿 USD | 7.29亿 USD | 7.19亿 USD | 6.36亿 USD | 5.53亿 USD |
| 折旧和摊销 | 29.58亿 USD | 28.61亿 USD | 26.47亿 USD | 26.97亿 USD | 27.07亿 USD |
| 营业利润 | 64.67亿 USD | 59.55亿 USD | 51.44亿 USD | 54.85亿 USD | 57.52亿 USD |
| 净利润 | 48亿 USD | 46.62亿 USD | 36.76亿 USD | 37.58亿 USD | 50.39亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$97.73
上涨空间 6.31%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 1999年9月27日 | 2:1 | — | — |
股票拆分 | 1997年9月15日 | 2:1 | — | — |
股票拆分 | 1995年9月29日 | 2:1 | — | — |
股票拆分 | 1994年9月30日 | 2:1 | — | — |
股票拆分 | 1991年8月30日 | 2:1 | — | — |
股票拆分 | 1989年8月31日 | 2:1 | — | — |
已生效 1999年9月27日
2:1
已生效 1997年9月15日
2:1
已生效 1995年9月29日
2:1
已生效 1994年9月30日
2:1
已生效 1991年8月30日
2:1
已生效 1989年8月31日
2:1
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T2179.07亿0.17%130.34万亿 JPY0.09%JP¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI36.98亿0.16%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO30.92亿0.18%1.8万亿 USD0.03%US$715.13-0.06%
iShares Core S&P 500 ETFIVV15.06亿0.17%8964.4亿 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY13.73亿0.17%8216.79亿 USD0.09%US$778.1-0.06%
Vanguard Morningstar Value ETFVTV11.13亿0.42%2624亿 USD0.03%US$221.43+0.38%
State Street Health Care Select Sector SPDR ETFXLV7.94亿1.82%443.1亿 USD0.08%US$171.99+0.69%
Vanguard Dividend Appreciation ETFVIG6.59亿0.50%1324亿 USD0.04%US$240.04+0.41%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。